MedTrace Logo

GAS-Hem Feasibility Study

NCT02674997 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2021-03-17

No results posted yet for this study

Summary

The purpose of this study is to investigate the feasibility and acceptability of the Standardized Goal Attainment Scaling menu for Hemophilia (GAS-Hem) as a patient reported outcome (PRO) measure to monitor clinical progress in participant-identified goal areas in individuals with hemophilia A.

Conditions

Interventions

BIOLOGICAL

Factor VIII

Licensed Factor VIII products. Study is brand agnostic

Sponsors & Collaborators

  • Baxalta now part of Shire

    lead INDUSTRY

Principal Investigators

  • Study Director · Takeda

Eligibility

Min Age
5 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-05
Primary Completion
2016-11-02
Completion
2016-11-02

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02674997 on ClinicalTrials.gov